Orelabrutinib Uses, Dosage, Side Effects and more
Orelabrutinib is under investigation in clinical trial NCT04305197 (A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)).
| Attribute | Details |
|---|---|
| Trade Name | Orelabrutinib |
| Generic | Orelabrutinib |
| Orelabrutinib Other Names | Orelabrutinib |
| Type | |
| Formula | C26H25N3O3 |
| Weight | Average: 427.504 Monoisotopic: 427.189591677 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
